"Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, Horse, Cattle, Pig, Poultry),End User (Veterinary Reference Labs, Universities) - Global Forecast to 2026", published by MarketsandMarkets™, the Veterinary AST Market is expected to reach USD 135 million by 2026 from an estimated USD 100 million in 2021, at a CAGR of 6.1%.
Browse in-depth TOC on "Veterinary
Antimicrobial Susceptibility Testing Market"
169 – Tables
62 – Figures
227 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=50401056
Growth in the market is largely driven by the growing threat of
antimicrobial resistance due to the overuse of antibiotics, rising demand for
animal-derived products, growing prevalence of zoonotic diseases, rising demand
for pet insurance, growing animal health expenditure, and the growing number of
veterinary practitioners & their rising income levels in developed
economies. The rising focus on veterinary antimicrobial susceptibility testing
in emerging markets due to supportive government initiatives and awareness
initiatives for antimicrobial resistance and control offer significant growth
opportunities for the market players. On the other hand, the high cost of
automated veterinary AST systems and rising pet care costs are expected to
restrain the overall market growth to a certain extent.
Since the beginning of 2020, the majority of the countries
worldwide shut down their borders and limited transportation in a bid to
contain the coronavirus (COVID-19) outbreak, thus, creating impediments for
international trade and transportation.
The food-producing animal segment is expected to account for the
largest share of the veterinary AST market
Based on animal type, the veterinary antimicrobial
susceptibility testing market is segmented into food-producing animals and
companion animals. The food-producing animals segment accounted for the largest
share of the market in 2020. The large share and high growth of this segment
can be attributed to the high use of antibiotics in food-producing animals,
increasing incidence of antimicrobial resistance, increasing demand for meat
and dairy products, rising animal healthcare expenditure in developed
countries, and the increasing incidence of disease outbreaks in food-producing
animals. This segment is further categorized into cattle, pigs, poultry, and
other food-producing animals. Companion animals are further segmented into dogs,
cats, horses, and other companion animals.
The culture media segment is expected to grow at the highest
rate during the forecast period
The culture media segment is expected to register the highest
growth rate during the forecast period. Growth in this product segment can be
attributed to the constant requirement and recurrent purchase of these products
for cultivating bacterial isolates under controlled environmental laboratory
conditions.
The veterinary reference laboratory end-user segment is expected
to account for the largest share of the veterinary AST market
Based on end users, the veterinary antimicrobial susceptibility
testing market is segmented into veterinary reference laboratories, veterinary
research institutes and universities, and other end users. Veterinary reference
laboratories accounted for the largest share of the market in 2020. The large
share of this segment can be attributed to the large number of samples received
for AST in reference laboratories from small and large animal practices. This
segment is also expected to register the highest growth during the forecast
period (2021–2026).
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=50401056
Asia Pacific is expected to account for the highest CAGR for players
operating in the veterinary AST market
The Asia Pacific region is expected to register the
highest CAGR during the forecast period. Growth in pet adoption, increasing
awareness about animal health, and the growing per capita animal health
expenditure, especially in India and China, contribute to the
growth of the APAC antimicrobial susceptibility testing market.
Some of the major players in the veterinary antimicrobial
susceptibility testing market include Thermo Fisher Scientific Inc. (US),
Becton, Dickinson and Company (US), Bruker Corporation (US), bioMérieux SA (France), Danaher Corporation
(US), Bio-Rad Laboratories, Inc. (US), Neogen Corporation (US), HiMedia
Laboratories (India), Mast Group Ltd. (UK), Bioguard Corporation (Taiwan), SSI Diagnostica A/S
(Denmark), Condalab (Spain), FASTinov SA (Portugal), Synbiosis (UK),
Hardy Diagnostics (US), and Liofilchem Srl (Italy).
No comments:
Post a Comment